Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Epsilon Healthcare Limited ( (AU:EPN) ).
Epsilon Healthcare Limited has announced a change in its external auditor, appointing RSM Australia effective December 16, 2025. This decision is part of the company’s commitment to strong corporate governance and aligning its audit framework with operational needs and strategic growth objectives, following the resignation of A D Danieli Audit with ASIC’s consent.
The most recent analyst rating on (AU:EPN) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Epsilon Healthcare Limited stock, see the AU:EPN Stock Forecast page.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited (ASX: EPN) is an Australian-based, globally active healthcare organization. It operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacture, and pharmacy dispensing and information services.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.21M
For detailed information about EPN stock, go to TipRanks’ Stock Analysis page.